Jordi Xaus

Chief Tech/Sci/R&D Officer at ORYZON GENOMICS S.A.

Health Technology

Consumer Services

Profile

Jordi Xaus is currently the Chief Scientific Officer at Oryzon Genomics SA since 2021.
Previously, he worked as the Director & Biomedicine Director at Biosearch SA. He also served as an Associate Professor at the University of Barcelona from 2000 to 2001.
Additionally, he held the position of Chief Scientific Officer at Palau Pharma SA. Dr. Xaus obtained a doctorate degree from the University of Barcelona in 1994, followed by a graduate degree in 1997.
He later earned another graduate degree from Ramon Llull University in 2009.

Jordi Xaus active positions

Companies	Position	Start
ORYZON GENOMICS S.A.	Chief Tech/Sci/R&D Officer	2021-06-30

All active positions of Jordi Xaus

Former positions of Jordi Xaus

Companies	Position	End
University of Barcelona	Corporate Officer/Principal	2000-12-31
BIOSEARCH, S.A.	Director/Board Member	-
Palau Pharma SA Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain.	Chief Tech/Sci/R&D Officer	-

See the detail of Jordi Xaus's experience

Training of Jordi Xaus

University of Barcelona	Doctorate Degree
Ramon Llull University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jordi Xaus's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ORYZON GENOMICS S.A.	Health Technology

Private companies	2
Biosearch SA Biosearch SA Pharmaceuticals: OtherHealth Technology Biosearch SA engages in the provision of products for pharmaceutical, nutritional, and functional food sectors. It develops and markets three product platforms including Omega-3, Probiotics and Botanical Extracts. The company was founded on September 12, 2000 and is headquartered in Granada, Spain.	Health Technology
Palau Pharma SA Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain.	Health Technology